CZ20012866A3 - Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu - Google Patents

Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu Download PDF

Info

Publication number
CZ20012866A3
CZ20012866A3 CZ20012866A CZ20012866A CZ20012866A3 CZ 20012866 A3 CZ20012866 A3 CZ 20012866A3 CZ 20012866 A CZ20012866 A CZ 20012866A CZ 20012866 A CZ20012866 A CZ 20012866A CZ 20012866 A3 CZ20012866 A3 CZ 20012866A3
Authority
CZ
Czechia
Prior art keywords
cholesta
dimethyl
5alpha
compounds
3beta
Prior art date
Application number
CZ20012866A
Other languages
Czech (cs)
English (en)
Inventor
Thorsten Blume
Peter Esperling
Joachim Kuhnke
Christa Hegele-Hartung
Monika Lessl
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of CZ20012866A3 publication Critical patent/CZ20012866A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ20012866A 1999-02-10 2000-02-09 Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu CZ20012866A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99250040 1999-02-10

Publications (1)

Publication Number Publication Date
CZ20012866A3 true CZ20012866A3 (cs) 2002-01-16

Family

ID=8241140

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20012866A CZ20012866A3 (cs) 1999-02-10 2000-02-09 Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu

Country Status (15)

Country Link
EP (1) EP1150993A1 (no)
JP (1) JP2002536456A (no)
KR (1) KR20010101820A (no)
CN (1) CN1368977A (no)
AU (1) AU3279700A (no)
BR (1) BR0008065A (no)
CA (1) CA2359687A1 (no)
CZ (1) CZ20012866A3 (no)
HU (1) HUP0200280A2 (no)
IL (1) IL143735A0 (no)
NO (1) NO20013901D0 (no)
PL (1) PL350557A1 (no)
SK (1) SK11382001A3 (no)
WO (1) WO2000047604A1 (no)
ZA (1) ZA200107387B (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
AU717180B2 (en) * 1995-03-06 2000-03-16 Novo Nordisk A/S Stimulation of meiosis
RU2182909C2 (ru) * 1995-06-23 2002-05-27 Ново Нордиск А/С Стероиды, способ регулирования мейоза
JP2001506656A (ja) * 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物

Also Published As

Publication number Publication date
SK11382001A3 (sk) 2002-01-07
EP1150993A1 (en) 2001-11-07
HUP0200280A2 (hu) 2002-07-29
CA2359687A1 (en) 2000-08-17
CN1368977A (zh) 2002-09-11
KR20010101820A (ko) 2001-11-14
ZA200107387B (en) 2002-12-06
IL143735A0 (en) 2002-04-21
PL350557A1 (en) 2002-12-16
NO20013901L (no) 2001-08-10
WO2000047604A1 (en) 2000-08-17
BR0008065A (pt) 2001-11-06
NO20013901D0 (no) 2001-08-10
JP2002536456A (ja) 2002-10-29
AU3279700A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
US6884796B2 (en) Meiosis regulating compounds
US6486145B2 (en) Meiosis regulating compounds
EP1077992B1 (en) Use of meiosis regulating compounds
CZ20012866A3 (cs) Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu
EP1042353B1 (en) 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives
RU2289587C2 (ru) Стероидные соединения, способы их получения, фармацевтическая композиция, способы регуляции и совершенствования воспроизведения, промежуточные соединения
EP1162977B1 (en) (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for the control of fertility
MXPA01007526A (en) Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
US20020007079A1 (en) Meiosis regulating compounds
US6528501B1 (en) 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
KR20020013541A (ko) 14β-Ｈ-스테롤, 그를 포함하는 제약 조성물, 및 감수분열조절 약제 제조에 있어서 그의 유도체의 용도
RU2349597C2 (ru) Тиоморфолиновые производные стероидов, их применение для получения регулирующих мейоз лекарственных средств и способ получения этих соединений
CZ20004566A3 (cs) Nové sloučeniny, jejich použití, způsob regulace meiózy a nový znak
CZ213399A3 (cs) Sloučeniny regulující meiózu